Results 51 to 60 of about 5,637 (202)

Expression of the IL-11 Gene in Metastatic Cells Is Supported by Runx2-Smad and Runx2-cJun Complexes Induced by TGFβ1. [PDF]

open access: yes, 2015
In tumor cells, two factors are abnormally increased that contribute to metastatic bone disease: Runx2, a transcription factor that promotes expression of metastasis related and osteolytic genes; and IL-11, a secreted osteolytic cytokine.
Afzal   +59 more
core   +2 more sources

WWOX Oxidoreductase - Substrate and Enzymatic Characterization

open access: yesZeitschrift für Naturforschung C, 2011
WWOX is a tumour suppressor gene that spans the common fragile site FRA16D. Analysis of the WWOX expression pattern in normal human tissues showed the highest expression in testis, prostate, and ovary. Its altered expression has been demonstrated in different tissues and tumour types.
Anna, Sałuda-Gorgul   +3 more
openaire   +2 more sources

Genome-wide association analysis identifies six new loci associated with forced vital capacity [PDF]

open access: yes, 2014
Forced vital capacity (FVC), a spirometric measure of pulmonary function, reflects lung volume and is used to diagnose and monitor lung diseases. We performed genome-wide association study meta-analysis of FVC in 52,253 individuals from 26 studies and ...
A Bill Musk   +216 more
core   +4 more sources

Dynamic expression of genes associated with schizophrenia and bipolar disorder across development [PDF]

open access: yes, 2019
Common genetic variation contributes a substantial proportion of risk for both schizophrenia and bipolar disorder. Furthermore, there is evidence of significant, but not complete, overlap in genetic risk between the two disorders.
Clifton, Nicholas E.   +10 more
core   +3 more sources

WWOX guards genome stability by activating ATM [PDF]

open access: yesMolecular & Cellular Oncology, 2015
Common fragile sites (CFSs) tend to break upon replication stress and have been suggested to be "hot spots" for genomic instability. Recent evidence, however, implies that in the wake of DNA damage, WW domain-containing oxidoreductase (WWOX, the gene product of the FRA16D fragile site), associates with ataxia telangiectasia-mutated (ATM) and regulates ...
Hazan, Idit   +3 more
openaire   +2 more sources

A p53/TIAF1/WWOX triad exerts cancer suppression but may cause brain protein aggregation due to p53/WWOX functional antagonism

open access: yesCell Communication and Signaling, 2019
Background Tumor suppressor WWOX physically binds p53 and TIAF1 and together induces apoptosis and tumor suppression. To understand the molecular action, here we investigated the formation of WWOX/TIAF1/p53 triad and its regulation of cancer cell ...
Pei-Yi Chou   +5 more
doaj   +1 more source

The effects of protocadherin 8 and WWOX in prostate adenocarcinoma

open access: yesJournal of Men's Health, 2022
Objective: The protocadherin 8 (PCDH8) gene, located on chromosome 13q14.3 encodes an integral membrane protein. WWOX (fragile site FRA16D oxido-reductase) is a tumor suppressor gene located in region 16q23.324.1. The aim of this study was to investigate
Mürüvvet Akçay Çelik   +3 more
doaj   +1 more source

Delineating WWOX Protein Interactome by Tandem Affinity Purification-Mass Spectrometry: Identification of Top Interactors and Key Metabolic Pathways Involved

open access: yesFrontiers in Oncology, 2018
It has become clear from multiple studies that WWOX (WW domain-containing oxidoreductase) operates as a “non-classical” tumor suppressor of significant relevance in cancer progression.
Tabish Hussain   +4 more
doaj   +1 more source

WWOX promotes osteosarcoma development via upregulation of Myc

open access: yesCell Death & Disease, 2023
Abstract Osteosarcoma is an aggressive bone tumor that primarily affects children and adolescents. This malignancy is highly aggressive, associated with poor clinical outcomes, and primarily metastasizes to the lungs.
Rania Akkawi   +7 more
openaire   +3 more sources

Tumor suppressor WWOX and p53 alterations and drug resistance in glioblastomas

open access: yesFrontiers in Oncology, 2013
Tumor suppressor p53 are frequently mutated in glioblastomas (GBMs) and appears to contribute, in part, to resistance to temozolomide and therapeutic drugs.
Ming-Fu eChiang   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy